BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2768794)

  • 1. Indocyanine green intrinsic hepatic clearance as a prognostic index of survival in patients with cirrhosis.
    Merkel C; Bolognesi M; Finucci GF; Angeli P; Caregaro L; Rondana M; Gatta A
    J Hepatol; 1989 Jul; 9(1):16-22. PubMed ID: 2768794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
    Merkel C; Gatta A; Zoli M; Bolognesi M; Angeli P; Iervese T; Marchesini G; Ruol A
    Dig Dis Sci; 1991 Sep; 36(9):1197-203. PubMed ID: 1893804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of hepatic clearance of indocyanine green in patients with liver cirrhosis and hemorrhage of esophageal varices].
    Navasa M; García-Pagán JC; Bosch J; Rodés J
    Med Clin (Barc); 1992 Feb; 98(8):290-4. PubMed ID: 1560714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green retention test (ICG-r15) as a noninvasive predictor of portal hypertension in patients with different severity of cirrhosis.
    Pind ML; Bendtsen F; Kallemose T; Møller S
    Eur J Gastroenterol Hepatol; 2016 Aug; 28(8):948-54. PubMed ID: 27172450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between indocyanine green retention test, decompensation and survival in patients with Child-Pugh A cirrhosis and portal hypertension.
    Lisotti A; Azzaroli F; Cucchetti A; Buonfiglioli F; Cecinato P; Calvanese C; Simoni P; Arena R; Montagnani M; Golfieri R; Colecchia A; Festi D; Mazzella G
    Liver Int; 2016 Sep; 36(9):1313-21. PubMed ID: 26786880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indocyanine green retention test in cirrhosis and portal hypertension: Accuracy and relation to severity of disease.
    Møller S; la Cour Sibbesen E; Madsen JL; Bendtsen F
    J Gastroenterol Hepatol; 2019 Jun; 34(6):1093-1099. PubMed ID: 30221390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver.
    Gupta S; Chawla Y; Kaur J; Saxena R; Duseja A; Dhiman RK; Choudhary NS
    Trop Gastroenterol; 2012; 33(2):129-34. PubMed ID: 23025060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic hepatic clearance and Child-Turcotte classification for assessment of liver function in cirrhosis.
    Barbare JC; Poupon RE; Jaillon P; Prod'homme S; Darnis F; Poupon RY
    J Hepatol; 1985; 1(3):253-9. PubMed ID: 4067257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the ability of the PDD-ICG clearance test, CTP, MELD, and MELD-Na to predict short-term and medium-term mortality in patients with decompensated hepatitis B cirrhosis.
    Cheng XP; Zhao J; Chen Y; Meng FK; Xu B; Yu HW; Meng QH; Liu YM; Zhang SB; Meng S; Zhang JY; Zhang JY; Duan ZP; Zheng SJ
    Eur J Gastroenterol Hepatol; 2016 Apr; 28(4):444-8. PubMed ID: 26649802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limitations of use of the noninvasive clearance of indocyanine green as a prognostic indicator of graft function in liver transplantation.
    Escorsell À; Mas A; Fernández J; García-Valdecasas JC
    Transplant Proc; 2012; 44(6):1539-41. PubMed ID: 22841207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of hepatic clearance by derivations of the indocyanine green retention test in cirrhosis.
    Møller S; Henriksen JH; Sjöstedt S; Bendtsen F
    J Gastroenterol Hepatol; 2022 Apr; 37(4):692-699. PubMed ID: 35016257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of liver reserve function by ICGR15 detection before hepatectomy for hepatocellular carcinoma].
    Lao XM; Zhang YQ; Guan YX; Guo RP; Lin XJ; Yuan YF; Li JQ; Li GH
    Ai Zheng; 2004 Oct; 23(10):1213-7. PubMed ID: 15473939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of the evaluation of hepatic reticuloendothelial removal capacity in patients with cirrhosis.
    Bolognesi M; Merkel C; Bianco S; Angeli P; Sacerdoti D; Amodio P; Gatta A
    Hepatology; 1994 Mar; 19(3):628-34. PubMed ID: 8119687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incorporating indocyanin green clearance into the Model for End Stage Liver Disease (MELD-ICG) improves prognostic accuracy in intermediate to advanced cirrhosis.
    Zipprich A; Kuss O; Rogowski S; Kleber G; Lotterer E; Seufferlein T; Fleig WE; Dollinger MM
    Gut; 2010 Jul; 59(7):963-8. PubMed ID: 20581243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary sodium balance in patients with cirrhosis: relationship to quantitative parameters of liver function.
    Wensing G; Lotterer E; Link I; Hahn EG; Fleig WE
    Hepatology; 1997 Nov; 26(5):1149-55. PubMed ID: 9362355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of one-year pretransplant survival in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Binder L; Pichlmayr R
    Hepatology; 1991 Dec; 14(6):1029-34. PubMed ID: 1959850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pretransplant prognosis in patients with cirrhosis.
    Oellerich M; Burdelski M; Lautz HU; Rodeck B; Duewel J; Schulz M; Schmidt FW; Brodehl J; Pichlmayr R
    Transplantation; 1991 Apr; 51(4):801-6. PubMed ID: 2014533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of indocyanine green and lidocaine kinetics for survival and chronic hepatic encephalopathy in cirrhotic patients following elective end-to-side portacaval shunt.
    Pomier-Layrargues G; Huet PM; Infante-Rivard C; Villeneuve JP; Marleau D; Duguay L; Tanguay S; Lavoie P
    Hepatology; 1988; 8(6):1506-10. PubMed ID: 3192163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma renin concentration represents an independent risk factor for mortality and is associated with liver dysfunction in patients with cirrhosis.
    Paternostro R; Reiberger T; Mandorfer M; Schwarzer R; Schwabl P; Bota S; Ferlitsch M; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    J Gastroenterol Hepatol; 2017 Jan; 32(1):184-190. PubMed ID: 27164413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.